At least 20 million hepatitis E virus (HEV) infections occur annually, with> 3 million
symptomatic cases and∼ 60,000 fatalities. Hepatitis E is generally self-limiting, with a case …

During the past ten years, several new hepatitis E viruses (HEVs) have been identified in
various animal species. In parallel, the number of reports of autochthonous hepatitis E in …

Hepatitis E virus (HEV) is an important infection in humans in EU/EEA countries, and over
the last 10 years more than 21,000 acute clinical cases with 28 fatalities have been notified …

Hepatitis E is a rare human disease in developed countries. It is caused by hepatitis E virus
(HEV), which is probably transmitted zoonotically to humans from domestic pigs and wild …

Hepatitis E virus (HEV) is an important but extremely understudied pathogen. The
mechanisms of HEV replication and pathogenesis are poorly understood, and a vaccine …

Hepatitis E virus (HEV), as a hepatotropic virus, is supposed to exclusively infect the liver
and only cause hepatitis. However, a broad range of extrahepatic manifestations (in …

Hepatitis E virus (HEV), a single-stranded, positive-sense RNA virus, is responsible for acute
hepatitis E epidemics in many developing countries, and the virus is also endemic in some …

The hepatitis E virus (HEV) was first identified in 1990, although hepatitis E-like diseases in
humans have been recorded for a long time dating back to the 18th century. The HEV …

Hepatitis E virus (HEV) is an emerging zoonotic pathogen that has received an increasing
amount of attention from virologists, clinicians, veterinarians, and epidemiologists over the …

Hepatitis E viral infection recently emerges as a global health concern. Over the last decade,
the understanding of hepatitis E virus (HEV) had changed with the discovery of new …